Supplementary figures for Cladribine (2-CdA) improves cutaneous manifestations, DLQI and MC-QoL of patients with mastocytosis

Published: 9 January 2024| Version 1 | DOI: 10.17632/tk68xz7nmh.1
Contributors:
Hélène Bugaut, Hervé Maillard, Caroline Jacobzone Leveque,
,
,
,
,
,
,
, Stéphane Barete

Description

This set of supplementary figures illustrates additional content of the article "Cladribine (2-CdA) improves cutaneous manifestations, DLQI and MC-QoL of patients with mastocytosis"

Files

Institutions

Assistance Publique - Hopitaux de Paris, Sorbonne Universite, Hopitaux Universitaires Pitie Salpetriere-Charles Foix

Categories

Dermatology, Cladribine, Systemic Mastocytosis, Mastocytosis

Licence